cluster 2, 14.8% (66 of 447); cluster 3, 28.1% (36 of 128); and cluster 4, 51.2% (21 of 41; Fig 2) . The between sum of squares/total sum of squares was 93%. Revascularization benefit was greatest in limbs with small or moderate wounds, moderate to severe ischemia, and moderate to severe foot infection (W2 I2 fI3; W1 I3 fI2). Initially WIfI clinical stage 4, these presentations behaved as lower risk cluster 2 after revascularization. Multiple linear regression revealed wound grade most strongly predicted LEA (F-value 17.25; P < .001). Ischemia (F-value 6.51; P ¼ .001) and infection (F-value 5.7; P ¼ .003) were similarly associated with LEA risk. Interaction terms between each component of WIfI score were not significant.
cluster 2, 14.8% (66 of 447); cluster 3, 28.1% (36 of 128); and cluster 4, 51.2% (21 of 41; Fig 2) . The between sum of squares/total sum of squares was 93%. Revascularization benefit was greatest in limbs with small or moderate wounds, moderate to severe ischemia, and moderate to severe foot infection (W2 I2 fI3; W1 I3 fI2). Initially WIfI clinical stage 4, these presentations behaved as lower risk cluster 2 after revascularization. Multiple linear regression revealed wound grade most strongly predicted LEA (F-value 17.25; P < .001). Ischemia (F-value 6.51; P ¼ .001) and infection (F-value 5.7; P ¼ .003) were similarly associated with LEA risk. Interaction terms between each component of WIfI score were not significant.
Conclusions: WIfI is a promising tool to identify chronic limb-threatening ischemia presentations most likely to benefit from revascularization, and could be used to better inform patients, guide decision making, and risk-adjust quality and outcomes assessments. Wound severity is most strongly associated with LEA risk. Ischemic and infectious grades confer additive, but not synergistic, risk. Future cluster analyses comparing specific WIfI presentations treated with and without revascularization may quantify the benefit of revascularization for a given WIfI presentation and further refine the risk stratification provided by WIfI.
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SVS WIFi Does Not Predict Clinical Efficacy of Conservative Treatment in Select Patients With Peripheral Arterial Disease and Tissue Loss
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Objectives: The Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification system has been validated to predict wound healing and limb salvage among patients with peripheral arterial disease (PAD). Our goal was to evaluate the predictive ability of WIfI in patients with PAD and tissue loss who were stratified to a conservative approach in a multidisciplinary limb preservation program.
Methods: Veterans with PAD and tissue loss were prospectively enrolled into our Prevention of Amputation in Veterans Everywhere program. Limbs were stratified to a conservative approach based on perfusion evaluation and a validated pathway of care. Society for Vascular Surgery WIfI clinical stages (1-4) were assigned retrospectively. Rates of wound healing, wound recurrence, limb salvage, and survival were analyzed. Predictors of successful outcome were identified by univariate and subsequent multivariate analysis using Cox regression modeling.
Results: Between January 2006 and October 2017, 961 patients were prospectively enrolled in our Prevention of Amputation in Veterans Everywhere program. A total of 241 limbs with 281 wounds were stratified to the conservative approach. WIfI staging distribution included 19.1% stage I, 19.5% stage II, 39.8% stage III, and 21.6% stage IV wounds. Advanced wound interventions and minor amputations were performed on 40 limbs (16.6%) and 57 limbs (23.7%), respectively. The mean long-term follow-up was 41.4 6 29.0 months. Complete wound healing was achieved in 189 limbs (78.4%) over a mean of 4.4 6 4.1 months. Thirtyfour limbs (14%) received delayed revascularization owing to conservative treatment failure. An additional 22 limbs (9%) achieved wound healing after delayed revascularization. At long-term follow-up, wound recurrence was 48% among the conservative cohort and 14% among the delayed revascularization group (P ¼ .76). Overall limb salvage at longterm follow-up was 89.6%. When stratified by WIfI, there was no difference between groups for wound healing (P ¼ .51), wound recurrence (P ¼ .55), need for delayed revascularization (P ¼ .34), or limb salvage (P ¼ .58).
Conclusions: In patients with PAD and tissue loss, a stratified approach achieved acceptable rates of wound healing and limb salvage, with a limited need for delayed revascularization. WIfI presentation did not further predict wound healing, wound recurrence, need for delayed revascularization, or limb salvage. The selection of patients with PAD and tissue loss for conservative therapy is achieved with our clinical pathway independent of WIfI classification. Objectives: Patent pedal arteries in critical limb ischemia may not opacify during angiography. The purpose of this study is to evaluate limb salvage after exploration and bypass to radiographically nonvisualized pedal arteries.
Methods: A single institution database review between 2011 and 2016 of all foot explorations performed for bypass outflow in patients without suitable open or endovascular below-the-knee options. Demographics and outcomes were recorded and compared using Fisher exact probability.
Results: There were 22 patients (mean age, 67 years; range, 43-92 years) without angiographically identifiable pedal arteries who underwent foot exploration searching for outflow arteries. Our study cohort comprised 27% female and 73% male patients; 95% of patients had Rutherford class 5 or 6, of whom 81% were smokers and 45% diabetics. Eight patients had patent target arteries upon foot exploration: four to the dorsalis pedis artery, three to the plantar artery, and one to the tarsal artery. All bypasses were conducted with vein conduits (6 full-length and 2 spliced vein). The inflow arteries for bypass were femoral (n ¼ 3) and popliteal (n ¼ 5). Four of the bypassed patients resulted in limb salvage and four resulted in major amputations after early bypass failure. Of the 14 patients who did not receive a bypass, 12 required major amputation, 1 died perioperatively, and the only patient with Rutherford class 4 of the cohort remains amputation free. The bypass group was compared with the pedal exploration without bypass group using Fisher exact probability with end points of amputation or early death revealing significant (P ¼ .039) limb salvage rates.
Conclusions: Angiography is the gold standard for bypass planning; however, in some cases patent pedal arteries may not opacify secondary to poor flow. Exploration of angiographically nonvisualized pedal arteries may offer adequate outflow for bypass in extreme salvage situations.
Author Disclosures: B. Chang: Nothing to disclose; R. Darling: Nothing to disclose; J. Hnath: Nothing to disclose; D. Lee: Nothing to disclose; A. Ramdon: Nothing to disclose. Objectives: Limited data exist comparing atherectomy with balloon angioplasty for infrapopliteal peripheral arterial disease. The objective of this study was to compare the outcomes of infrapopliteal atherectomy vs angioplasty alone in patients with critical limb ischemia.
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Contemporary Outcomes of Infrapopliteal Atherectomy versus Balloon Angioplasty Alone for Critical Limb Ischemia at a Tertiary Care Teaching Institution
Methods: This is retrospective, single-center, longitudinal study compared patients undergoing either infrapopliteal atherectomy with or without angioplasty or angioplasty alone for critical limb ischemia, between January 2014 and October 2017. The primary outcome was primary patency rates. Secondary outcomes were reintervention rates, primary assisted patency rates, amputation rates, local complications, and mortality. Data were analyzed in multivariate generalized linear models with log-rank tests to determine survival in Kaplan-Meier curves. P < .05 was the threshold for significance.
Results: There were 342 infrapopliteal interventions performed on 290 patients at a mean age of 67.3 6 12.6 years; 61% were male. There were 183 angioplasties (53.5%) and 159 atherectomies (46.5%) performed. Angioplasty and atherectomy groups had similar demographics, comorbidities, numbers of patients with tissue loss (145 [ P ¼ .5119), mean followup (19.0 6 9.9 months vs 20.3 6 9.2 months; P ¼ .3231), mean number of vessels treated during the index procedure (1.7 6 0.8 vs 1.9 6 0.8; P ¼ .0318), and the mean lesion length treated (10.44 6 8.41 cm vs 9.05 6 6.73 cm; P ¼ .09), respectively. Primary patency rates at 3 months were 91.8% (168) for angioplasty versus 92.5% (147) P ¼ .08) interval patency rates were seen in 2 groups. There were 45 atherectomy patients (28.3%) who had reinterventions versus 29 angioplasty patients (15.8%; P ¼ .0058) with a median of 74 days before the need for reintervention. Diabetes was the only clinical factor associated with increased risk of reintervention (B ¼ 0.76; P ¼ .018) in both groups. Primary assisted patency rates were 86.3% (n ¼ 158) in angioplasty versus 76.1% (n ¼ 121) in atherectomy group (P ¼ .0174). Primary patency rates did not differ between the 2 groups (Fig 1) . The risk of reintervention was, however, greater in the atherectomy group (Fig 2) . The 30-day amputation rates (5 [2.7%] vs 6 [3.8%]; P ¼ .7606) and mortality rates (4 [2.2%] vs 2 [1.3%]; P ¼ .6894) were similar in the angioplasty and atherectomy groups, respectively. The atherectomy group had higher local complication rates (7 [4.4%] vs 1 [0.5%]; P ¼ .0273).
Conclusions: Atherectomy provides similar patency rates to angioplasty alone for infrapopliteal peripheral arterial disease, but is associated with higher reintervention and local complication rates. Further appropriately designed studies are required to determine the exact role of atherectomy in this subset of patients.
Author Disclosures: J. Deitch: Nothing to disclose; B. Faheem: Nothing to disclose; A. Juneja: Nothing to disclose; J. Schor: Nothing to disclose; S. Shams: Nothing to disclose; M. A. Shariff: Nothing to disclose; K. Singh: Nothing to disclose; S. Zia: Nothing to disclose.
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Increasing Objectives: Vascular surgery (VS) is projected to be one of the specialties with the highest growth needs to meet future demand in the United States. Over the past decade, the VS community has initiated multiple efforts to increase the supply of vascular surgeons. This study seeks to determine the effects of these efforts on current and future work force.
Methods: The available practicing physician data (from the American Board of Medical Specialties and American Medical Association) and graduate medical education information (National Resident Matching Program) were obtained from 2007 to 2017. The Healthcare Cost and Utilization Project Nationwide Inpatient Sample was queried for all vascular procedures performed on adult patients (age > 18) and population data were obtained from the U.S. Census Bureau.
Results: Between 2007 and 2014, there was an annual increase of 2.6% per year (907,198 to 1,071,105) in inpatient adult vascular procedures and an increase of 1.3% per year (237 to 245 million) in the adult population. During this time, there was a 43% increase (116 to 166) in available first year VS training positions per year with a 22% increase (133 to 162) in applicants annually. The match process resulted in a 35% increase (110 to 149) in trainees matched into first-year VS positions and a 21% increase (112 to 135) in new VS board certificates issued. The workforce data for VS compared with other specialties that participate in vascular care can be found in the Fig. Based on the assumption that trends in procedure volume increase remains constant and using population estimates, there is a need for an estimated 1833 additional vascular surgeons by 2030.
Conclusions: Despite the successful efforts leading to an increase in current supply of vascular surgeons, there remains a predicted deficit of vascular surgeons in the future. Increasing need and our aging workforce suggest a need to improve efforts for training and certifying vascular 
